Larger Absolute Rivaroxaban Benefit in Diabetes: COMPASS Larger Absolute Rivaroxaban Benefit in Diabetes: COMPASS

The new vascular low dose of rivaroxaban has gotten off to a slow start, but these new subgroup results may stimulate use in patients with diabetes and stable coronary or peripheral artery disease.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news